Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
about
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasiaBovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development.Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study.Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for SurveillanceA cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study.Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions: an observational study.Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.Human Papilloma Virus Persistence after Cone Excision in Women with Cervical High Grade Squamous Intraepithelial Lesion: A Prospective Study.National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United StatesA stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.Determination of malignant potential of cervical intraepithelial neoplasia.Probiotics for Treatment and Prevention of Urogenital Infections in Women: A Systematic Review.HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.Anal human papillomavirus infection prevalence in men who have sex with men is age-independent: a role for recent sexual behavior?Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study.Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer.FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).Age-related changes in the diagnostic assessment of women with severe cervical lesions.Conization as a marker of persistent cervical human papillomavirus (HPV) infection and risk of gastrointestinal cancer: a Danish 34-year nationwide cohort study.Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women.Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers.HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
P2860
Q24197474-202B31DF-A3F5-4B3C-95A9-68EA70F242CBQ33825330-5F67EB57-74B7-4F23-9520-38064AA843D0Q34467791-03FCB364-A1AA-4FEF-92C0-C40B440ECE26Q34610151-8ECF91DA-66DD-4BDE-A5FB-540732660D93Q36102386-5F7B700E-F80C-4E2F-A467-26859206DA81Q36141756-235939F8-C130-4FCB-BEE5-C186F3622490Q36157210-187978A3-341F-4760-8C44-5024F2B13399Q36675963-839EB19E-E6BA-4865-9D38-464B9AB45325Q36996829-9CCA1296-F2F4-414B-92A8-24289C37E2DDQ37173134-AC08CD3D-CC80-40AF-849A-3A0F9328C92AQ38288739-D5789E10-F861-4F6B-9D20-D783A3812725Q38676499-0AB902A7-19E6-4CEA-B0FF-30B4B671C8E4Q38842874-81551611-2B0E-40E7-BF52-AD7477C20867Q38930783-6D523821-77C1-471A-A468-9EF7CAF188A3Q39139975-ED139376-B8BF-40D3-B1DD-BE4F51097E03Q39933426-F54ED1C5-CBAB-45EF-AB7E-363EF693188EQ40648836-C8248CE3-A85E-4BCB-A4FF-B84EB16DDAB2Q40651861-34649584-3169-4F3E-811D-4928F1C70ACFQ41027688-269653CE-AD22-429F-B4FA-0AA197E60C04Q41533170-CD06D011-79F9-49FE-A6ED-EC3A054869A1Q41706167-AF75AE86-6FA7-45C8-8B75-78C13CFF22ACQ41923659-7FF207C8-6475-4469-9BB1-D26043F6CF90Q47239227-FAD3CBC4-049B-4554-BD4D-BAB3CE94DDBBQ47572365-A5E89CBE-D597-4249-9FCC-EA462F57F00AQ49907625-DBC87419-AEA4-41CC-A1C7-67936463DF36
P2860
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Natural history of progression ...... ge, randomised PATRICIA study.
@en
type
label
Natural history of progression ...... ge, randomised PATRICIA study.
@en
prefLabel
Natural history of progression ...... ge, randomised PATRICIA study.
@en
P2093
P2860
P50
P1433
P1476
Natural history of progression ...... ge, randomised PATRICIA study.
@en
P2093
Barbara Romanowski
Dominique Descamps
Dominique Rosillon
F Xavier Bosch
Fred Y Aoki
Gary O Dubin
HPV PATRICIA Study Group
James Hedrick
Johanna Palmroth
Julio C Teixeira
P2860
P304
P356
10.1371/JOURNAL.PONE.0079260
P407
P50
P577
2013-11-19T00:00:00Z